fig2

The role of melatonin as an adjuvant therapeutic strategy in the modulation of carcinogenesis. A narrative review

Figure 2. Melatonin-specific cellular receptors. AhR: Aryl hydrocarbon receptor; MT: melatonin receptor; QR2: quinine reductase.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/